#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA932801	B	Inhibition of [3H]spermidine uptake at PAT in mouse L1210 cells	Mus musculus	13		cell-based format	Scientific Literature
2.	ALA932802	F	Cytotoxicity against mouse L1210 cells after 48 hrs	Mus musculus	13		cell-based format	Scientific Literature
3.	ALA932803	F	Cytotoxicity against mouse L1210 cells in presence of ODC inhibitor difluoromethylornithine	Mus musculus	13		cell-based format	Scientific Literature
4.	ALA932804	F	Cytotoxicity against mouse L1210 cells after 24 hrs in presence of spermidine	Mus musculus	12		cell-based format	Scientific Literature
5.	ALA934015	A	Cytotoxicity against PAT deficient CHO-MG cells after 48 hrs	Cricetulus griseus	13		cell-based format	Scientific Literature
6.	ALA934016	A	Cytotoxicity against PAT active CHO cells after 48 hrs	Cricetulus griseus	13		cell-based format	Scientific Literature
7.	ALA934017	A	Ratio of IC50 for PAT deficient CHO-MG cells to IC50 for PAT active CHO cells	Cricetulus griseus	11		cell-based format	Scientific Literature
8.	ALA1654122	F	Antimicrobial activity against Pneumocystis carinii infected in Sprague-Dawley rat assessed as increase of host survival time at 0.5 mg/kg, intranasally every 2 days 28 days after infection	Pneumocystis carinii	2		organism-based format	Scientific Literature
9.	ALA1654123	A	Cytotoxicity against Sprague-Dawley rat alveolar macrophages assessed as cell viability at 2 mM after 3 hrs by trypan blue exclusion assay	Rattus norvegicus	3		cell-based format	Scientific Literature
10.	ALA1654125	U	Ratio of IC50 for polyamine uptake in CHO-MG cells to IC50 for polyamine transporter expressed in CHO cells		5		cell-based format	Scientific Literature
11.	ALA1654126	B	Inhibition of polyamine transporter expressed in CHO cells		5		cell-based format	Scientific Literature
12.	ALA1654127	F	Inhibition of polyamine uptake in CHO-MG cells	Cricetulus griseus	5		cell-based format	Scientific Literature
13.	ALA1654132	F	Antimicrobial activity against Pneumocystis carinii infected in Sprague-Dawley rat assessed as reduction of inflammatory cell infiltration at 0.5 mg/kg, intranasally every 2 days 28 days after infection for 21 days	Pneumocystis carinii	1		organism-based format	Scientific Literature
14.	ALA1654133	F	Antimicrobial activity against Pneumocystis carinii infected in Sprague-Dawley rat assessed as effect on alveolar structure at 0.5 mg/kg, intranasally every 2 days 28 days after infection for 21 days	Pneumocystis carinii	1		organism-based format	Scientific Literature
15.	ALA1654134	F	Antimicrobial activity against Pneumocystis carinii infected in Sprague-Dawley rat assessed as effect on foamy exudates in alveoli at 0.5 mg/kg, intranasally every 2 days 28 days after infection for 21 days	Pneumocystis carinii	1		organism-based format	Scientific Literature
16.	ALA1654135	F	Antimicrobial activity against Pneumocystis carinii infected in Sprague-Dawley rat assessed as reduction of organism burden in lungs at 0.5 mg/kg, intranasally every 2 days 28 days after infection for 21 days	Pneumocystis carinii	2		organism-based format	Scientific Literature
17.	ALA1654136	F	Antimicrobial activity against Pneumocystis carinii infected in Sprague-Dawley rat assessed as reduction of number of apoptotic alveolar macrophages at 0.5 mg/kg, intranasally every 2 days 28 days after infection for 21 days	Pneumocystis carinii	2		organism-based format	Scientific Literature
18.	ALA2406442	F	Cytotoxicity against human MALME-3M cells assessed as cell viability at 0.01 uM after 96 hrs in presence of spermidine	Homo sapiens	2		cell-based format	Scientific Literature
19.	ALA2406443	A	Cytotoxicity against human MALME-3 cells assessed as cell viability at 0.1 uM after 96 hrs in presence of spermidine	Homo sapiens	1		cell-based format	Scientific Literature
20.	ALA2404256	A	Selectivity ratio of IC50 for human MALME-3 cells to IC50 for polyamine transport system-mediated compound uptake in human MALME-3M cells in presence of aminoguanidine	Homo sapiens	8		cell-based format	Scientific Literature